PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 61 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,327,000 | -52.3% | 101,966 | -49.0% | 0.12% | -63.5% |
| Q2 2016 | $2,782,000 | +104.9% | 200,000 | +123.4% | 0.34% | +82.2% |
| Q1 2016 | $1,358,000 | -49.4% | 89,531 | -36.7% | 0.18% | -28.8% |
| Q4 2015 | $2,682,000 | +4.0% | 141,367 | +4.2% | 0.26% | +15.6% |
| Q3 2015 | $2,578,000 | -28.5% | 135,710 | -3.1% | 0.22% | -12.1% |
| Q2 2015 | $3,607,000 | – | 140,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |